Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35531 | 0.94 | PIK3CD (0.35) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL195053 | 0.86 | — | — | |
| SCHEMBL28071990 | 0.77 | CYP3A4 (0.39) | ALDH1A1 | |
| SCHEMBL6926233 | 0.77 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL868162 | 0.76 | PIK3CD (0.30) | PIK3CD | |
| SCHEMBL18289478 | 0.76 | ALDH1A1 (0.33) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL7238109 | 0.74 | CHRNB2 (0.34) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL10033658 | 0.73 | — | — | |
| SCHEMBL3142692 | 0.72 | CHRM2 (0.32) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL868861 | 0.72 | ALDH1A1 (0.36) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4707315-A1 | COPOLYMER, COMPOSITION AND USE THEREOF | Beijing Mapu New Materials Co., Ltd. (CN) | 2026-03-11 | — | — | EP | claimed |
| WO-2024245366-A1 | COPOLYMER, COMPOSITION AND USE THEREOF | 北京马普新材料有限公司 | 2024-12-05 | — | — | WO | claimed |
| CN-117716262-A | Method for producing wettable silicone hydrogel contact lenses | 爱尔康公司 | 2024-03-15 | — | — | CN | claimed |
| CN-116874664-A | Copolymer for paper product treatment, treatment method and product | 北京马普新材料有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-116789898-A | Copolymer, composition and application thereof | 北京马普新材料有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-107531850-B | Use of a composition for bleaching teeth | 巴斯夫欧洲公司 | 2022-01-11 | — | — | CN | claimed |
| CN-113677719-A | Modified high-cis polydiene polymers, related methods, and rubber compositions | 株式会社普利司通 | 2021-11-19 | — | — | CN | claimed |
| EP-3288532-B1 | POLYMERS FOR THE STABILISATION OF PEROXIDE COMPOUNDS | BASF SE (DE) | 2021-06-23 | — | — | EP | claimed |
| US-20210155728-A1 | METHOD OF PREPARING BLOCK COPOLYMER AND THERMO-SENSITIVE CELL CULTURE SUBSTRATE HAVING THE BLOCK COPOLYMER | QINGDAO AMA CO., LTD (CN) | 2021-05-27 | — | — | US | claimed |
| EP-3288533-B1 | POLYMERS FOR THE STABILISATION OF PEROXIDE LINKS | BASF SE (DE) | 2020-08-19 | — | — | EP | claimed |
| US-20180093113-A1 | POLYMERS FOR STABILISING PEROXIDE COMPOUNDS | BASF SE (DE) | 2018-04-05 | — | — | US | claimed |
| EP-3288533-A1 | USE OF A COMPOSITION FOR BLEACHING TEETH | BASF SE (DE) | 2018-03-07 | — | — | EP | claimed |
| EP-3288532-A1 | POLYMERS FOR STABILISING PEROXIDE COMPOUNDS | BASF SE (DE) | 2018-03-07 | — | — | EP | claimed |
| WO-2016173869-A1 | POLYMERS FOR STABILISING PEROXIDE COMPOUNDS | BASF SE (DE) | 2016-11-03 | — | — | WO | claimed |
| WO-2016173871-A1 | USE OF A COMPOSITION FOR BLEACHING TEETH | BASF SE (DE) | 2016-11-03 | — | — | WO | claimed |
| US-9120249-B2 | Implant device release agents and methods of using same | ENDO PHARMACEUTICALS SOLUTIONS INC. (US) | 2015-09-01 | — | — | US | claimed |
| CN-101720239-B | Implant device release agent and method of use thereof | ENDO PHARMACEUTICALS SOLUTIONS | 2013-12-04 | — | — | CN | claimed |
| US-20120301522-A1 | PEROXIDE-STABILIZED ABRASIVE TOOTH WHITENING COMPOSITIONS, PROCESS FOR PREPARING AND METHOD OF USE | ISP INVESTMENTS INC. (US) | 2012-11-29 | — | — | US | claimed |
| CN-101720239-A | Implant device release agent and method of use thereof | ENDO PHARMACEUTICALS SOLUTIONS | 2010-06-02 | — | — | CN | claimed |
| US-20080311170-A1 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | INDEVUS PHARMACEUTICALS, INC. | 2008-12-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311170-A1 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | PTGES, VDR, HPGDS | CHRM2 1220/4885CHRM4 1459/4885CHRM5 488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.